Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Introduces microRNA qPCR Panels for Stem Cell Research

Published: Wednesday, April 18, 2012
Last Updated: Wednesday, April 18, 2012
Bookmark and Share
Scientists to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

Exiqon A/S has launched microRNA qPCR panels for stem cell research.
The new Stem Cell Focus microRNA PCR Panels allow scientists interested in stem cell research to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

The 85 qPCR and 11 control assays have been experimentally optimized and validated to fit the needs of researchers interested in differentiation, proliferation, development and homeostasis of stem cells.

Recent research has documented the importance of microRNAs in the differentiation of stem cells as microRNAs are directly involved in determining the fate of the undifferentiated stem cells and in the process of inducing pluripotency of differentiated cells.

The Stem Cell Focus microRNA PCR Panels offered by Exiqon are perfectly suited for testing the degree and type of differentiation as well as the quality of the differentiation.

In a comment, Senior Vice President Sales & Marketing Henrik M. Pfundheller said: “We understand from our customers that they only have access to very limited sample material. We are therefore offering a product that only requires a 10 µl reaction volume and can detect down to 5 copies of microRNAs which is unprecedented in the market”.

He added: “Also microRNAs with high sequence content of A and T that are normally hard to detect are readily detected due to the inclusion of LNA™ in the PCR primers”.

The Stem Cell Focus microRNA PCR Panels are based on the most sensitive microRNA qPCR platform available with required sample input of as little as 1 pg of total RNA without any need for pre-amplification and thus avoiding risk of introducing bias in the generation of cDNA due to the unique universal RT step.

All major brands of qPCR instruments are supported by the Stem Cell Focus microRNA PCR Panels including instruments for both 96 and 384 well array formats.

The Stem Cell Focus microRNA PCR Panels are fully compatible with all other products in the miRCURY LNA™ Universal RT microRNA PCR system product line including the data analysis software. The entire work process from sample to data can be completed in 3 hours.

Exiqon offers a complete range of PCR products for the microRNA analysis which includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs, numerous other focus panels, the fully flexible Pick & Mix panels, spike in kits, as well as RT and Master Mix kits, sample preparation and a unique qPCR data analysis software.

If customers have identified proprietary microRNAs and would like to take advantage of Exiqon’s proprietary LNA™ chemistry and unique RT technology, Exiqon also offers an easy to use design software for high quality design of custom microRNA qPCR assays.

The miRCURY LNA™ microRNA PCR is also accessible via Exiqon Services.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Announces 2012 Grant Program for MicroRNA Research
The company announced the launch of its 2012 global research grant program, open to researchers from academic and non-profit institutions.
Thursday, January 05, 2012
Exiqon and Roswell Park Sign Center of Excellence Agreement
Roswell Park to provide real-time PCR services based on Exiqon’s miRCURY LNA™ Universal RT microRNA PCR product line.
Friday, October 07, 2011
Exiqon to Present New Data at AACR Conference
Data from company’s diagnostic program on early detection of colorectal cancer in plasma has been selected for oral presentation at the 102nd AACR.
Monday, April 11, 2011
Scientific News
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Using Cancer Cells' Mass to Predict Treatment Response
A device has been developed that can detect changes in cell mass at a minute scale.
NVIDIA Awards $400k to Trailblazers in Cancer Research
NVIDIA Foundation furthers research that could lead to new and more targeted treatments with investments.
Malaria Parasite Evades Rapid Test Detection in Children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Working With Advanced Nanoimagers
Oxford Nanoimaging report on the work of early-adopters for their Nanoimager technology at the MRC Centre for Molecular Bacteriology and Infection.
History of Cells Told Through MEMOIR
MEMOIR technique developed by CalTech researchers enables the life history of cells to be read.
Nanoscale ‘Muscles’ Powered by DNA
Scientists have developed nanoscale "muscles" to integrate with custom DNA, that can force the material to bend, curl and flip.
Dissecting Bacterial Infections at the Single-Cell Level
Researchers have used single-cell analysis technology to provide new insight into the Salmonella infection process.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Cancer Stem Cells Fuel Tumor Growth
Mass. General, Broad Institute team finds strong evidence that cancer stem cells are important drivers of tumors in patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!